Insider Buying: Aprea Therapeutics, Inc. (NASDAQ:APRE) Director Buys 10,000 Shares of Stock
Aprea Therapeutics, Inc. (NASDAQ:APRE – Get Free Report) Director Bernd R. Seizinger bought 10,000 shares of the firm’s stock in a transaction dated Friday, October 11th. The stock was purchased at an average cost of $2.68 per share, with a total value of $26,800.00. Following the transaction, the director now directly owns 44,730 shares in […]
More Stories
EMS-CHEMIE HOLDING AG (OTCMKTS:EMSHF) Short Interest Up 19.7% in September
EMS-CHEMIE HOLDING AG (OTCMKTS:EMSHF – Get Free Report) was the target of a significant increase in short interest during the...
China Construction Bank Co. (OTCMKTS:CICHF) Sees Significant Increase in Short Interest
China Construction Bank Co. (OTCMKTS:CICHF – Get Free Report) was the target of a significant growth in short interest in...
PepsiCo, Inc. (NASDAQ:PEP) Shares Sold by ERn Financial LLC
ERn Financial LLC lowered its stake in shares of PepsiCo, Inc. (NASDAQ:PEP – Free Report) by 1.0% during the third...
Kapitalo Investimentos Ltda Makes New $324,000 Investment in Duke Energy Co. (NYSE:DUK)
Kapitalo Investimentos Ltda purchased a new stake in Duke Energy Co. (NYSE:DUK – Free Report) during the 3rd quarter, according...
626 Financial LLC Has $571,000 Holdings in Salesforce, Inc. (NYSE:CRM)
626 Financial LLC decreased its position in Salesforce, Inc. (NYSE:CRM – Free Report) by 9.9% in the third quarter, according...
Acorn Creek Capital LLC Purchases Shares of 907 International Business Machines Co. (NYSE:IBM)
Acorn Creek Capital LLC purchased a new stake in International Business Machines Co. (NYSE:IBM – Free Report) during the third...